Jan P. Nicolay

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 580 citations

Medicine, Hematology, Oncology +12

Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide

Philipp A. Lang, M. Schenck, Jan P. Nicolay et al. · Nature Medicine · 2007 · 441 citations

Medicine, Biochemistry, Cell Biology +14

Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome

Philipp A. Lang, Ortraud Beringer, Jan P. Nicolay et al. · Journal of Molecular Medicine · 2006 · 239 citations

Medicine, Hematology, Nephrology +14

Stimulation of Suicidal Erythrocyte Death by Methylglyoxal

Jan P. Nicolay, Juliane Schneider, Olivier M. Niemoeller et al. · Cellular Physiology and Biochemistry · 2006 · 226 citations

Life Sciences, Cell Biology, Pharmacology +17